ClinConnect ClinConnect Logo
Search / Trial NCT06901895

Comparing Effect of Hyaluronic Acid and Lipid Coated Carbomer Gel on Dry Eyes After Phacoemulsification in DP

Launched by SUPERIOR UNIVERSITY · Mar 28, 2025

Trial Information

Current as of April 26, 2025

Active, not recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how effective two different eye lubricants—hyaluronic acid and lipid-coated carbomer gel—are for treating dry eyes in diabetic patients after they have cataract surgery. The researchers are interested in seeing how well these lubricants work by checking the tear film in patients before the surgery and again two weeks and four weeks after the surgery.

To participate in this study, patients need to have a recent case of acute dry eye before their cataract surgery. However, those with a long-term (chronic) dry eye condition are not eligible. The trial is currently active, and participants can expect to have their eye health monitored closely during the post-surgery period to determine which lubricant helps alleviate their dry eye symptoms more effectively.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients who have acute dry eye condition before phacoemulsification cataract surgery.
  • Exclusion Criteria:
  • Patients who have chronic dry eye condition before phacoemulsification cataract surgery.

About Superior University

Superior University is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in education and patient care, the university fosters a collaborative environment that brings together multidisciplinary teams of researchers, clinicians, and students. Superior University is focused on exploring novel therapeutic approaches and improving patient outcomes, leveraging its state-of-the-art facilities and cutting-edge technology. The institution adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and impact of its clinical research initiatives.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported